1500 visits available
3788 doctors
1800 blood tests and services
Verified opinions
Medistore
- Medistore
- Diagnostic tests
- Cancer tests
Cancer tests
Utilizing the most advanced methods of molecular biology, these tests analyze the patient's DNA for genetic mutations that increase the likelihood of developing cancer. Early detection of predispositions to cancer allows for the implementation of appropriate preventive measures, planning of regular check-ups, and making informed health and lifestyle decisions. Check out the tests available at Medistore!
ForeSENTIA Pan-Cancer Plus tumor molecular profile - comprehensive panel 222 genes
ForeSENTIA Pan-Cancer is an advanced oncogenetic test that allows molecular profiling of the tumor. This makes it possible to apply targeted therapy tailored to the individual patient's needs.
ForeSENTIA Pan-Cancer molecular profile of the tumor - baseline panel of 80 genes
ForeSENTIA Pan-Cancer is an advanced oncogenetic test that allows molecular profiling of the tumor. This makes it possible to apply targeted therapy tailored to the individual patient's needs.
NeoThetis Liquid Biopsy- Comprehensive Panel 222 Genes
NeoThetis is an innovative, non-invasive liquid biopsy test that helps patients with cancer select the optimal treatment.
Cancer marker CA 19-9
The CA 19-9 tumor marker is a protein measured in the blood, often elevated in cases of gastrointestinal cancers, especially pancreatic cancer. This marker test is performed for diagnosis, monitoring treatment, and assessing disease progression and recurrence in cancers such as pancreatic cancer or colorectal cancer.
from
PLN 42.00
Cancer marker CA 15-3
The CA 15-3 tumor marker is a protein whose blood levels are often elevated in patients with breast cancer. This marker test is performed to monitor treatment, assess the effectiveness of therapy, and for early detection of breast cancer recurrence.
from
PLN 47.50
Inflammatory cytokine profile
A group of proteins is assessed, the levels of which influence the regulation of the immune response. The test is performed in the diagnosis of female infertility, in diagnosing inflammatory conditions and diseases with an inflammatory pathogenesis, and in monitoring the effects of therapy for certain cancers.
PLN 326.80
Liquid-based cytology - LBC + Chlamydia tr. + Ureaplasma sp. + Mycoplasma g. with sample collection at a medical centre
The test allows for the quick diagnosis of cervical cancer lesions caused by the HPV virus, which are in a very early, asymptomatic phase. The test additionally looks for infection with Chlamydia, Ureaplasma and Mycoplasma microorganisms.
from
PLN 598.50
Liquid-based cytology (LBC) of the cervix with HPV 28 genotyping with sample collection at a medical centre
Liquid-based cytology detects about 64% more high-risk lesions than conventional cytology and enables the early detection of human papillomavirus (HPV) infection – the virus that causes cervical cancer. Meanwhile, LBC with HPV-28 genotyping also makes it possible to determine the specific HPV type that can lead to cancer, making it easier to assess risk and increasing the chances of a complete cure.
from
PLN 359.28
Premium DNA test: Most comprehensive report into your genetic blueprint with 120+ analyses
Unlock the full potential of your genetic makeup with our Premium DNA test. This package combines the insights of MyLifestyle, MyHealth, MyAncestry, and MyOral, offering a holistic view of your health, lifestyle, ancestry, and oral microbiome through more than 120 analyses.
PLN 1,492.50
MyHealth DNA test: Discover your disease risks
Not everyone is at the same risk of developing the disease - Find out what your genes say about it. MyHealth provides over 20 insights on various types of cancer, cardiovascular disease and other conditions. This test is based on a saliva sample.
PLN 1,042.50
Cancer as a Genetic Disease
Cancers arise as a result of changes (mutations) in the DNA of cells. These changes disrupt the normal functioning of cells, leading to uncontrolled growth and division.
Mutations can be inherited from parents (hereditary predispositions) or acquired during a person’s lifetime.
Cancer Risk
The risk of developing cancer can affect anyone, but there are groups of people who are particularly at risk of developing cancer.
High-risk groups include individuals with a family history of cancer, especially among close relatives (parents, siblings). High cancer risk is usually associated with cancers such as breast cancer, ovarian cancer, or colorectal cancer.
What Do Genetic Cancer Tests Involve?
Genetic cancer tests are based on advanced diagnostic methods that allow an in-depth look at DNA. These tests make it possible to detect changes that may increase the risk of developing cancer. The process begins by collecting a sample of genetic material, usually a blood or saliva sample.
Genetic tests can be targeted at specific types of cancers, such as breast cancer or colorectal cancer. In these cases, scientists focus on analyzing specific genes, such as the BRCA1 and BRCA2 genes for breast cancer. They can also cover a wide range of genes, analyzing all possible mutations.
Genetic tests allow for:
- Assessment of the risk of developing specific types of cancer.
- Early detection of cancerous changes.
- Selection of appropriate treatment.
Types of Genetic Tests for Cancer
It is worth noting that Medistore offers both individual tests and comprehensive diagnostic packages. These packages allow for a broader analysis of predispositions to various types of cancers, which may be particularly beneficial for individuals in high-risk groups.
All these tests use advanced molecular biology methods to analyze the patient’s DNA, enabling early detection of potential risks and the implementation of appropriate preventive measures.
The most popular packages include screenings for genetic predispositions to breast and ovarian cancer, prostate cancer, colorectal cancer, kidney cancer, as well as genetic predisposition tests for cancers of the digestive system.
Who Should Undergo Genetic Cancer Tests?
Genetic cancer tests should especially be taken by people:
- with genetic predispositions,
- with clinical symptoms characteristic of cancer,
- who have previously had cancer.
Sometimes identifying a genetic mutation can help in the faster diagnosis and treatment of the disease.